Alvotech (ALVO) Cash from Investing Activities (2022 - 2026)
Alvotech's (ALVO) quarterly Cash from Investing Activities came in at -$44.8 million in Q2 2026, down 56.53% on a YoY basis from -$103.0 million in Q2 2025, and up 3.08% quarter-over-quarter from -$46.2 million in Q1 2026.
Powered by 
Analysis
Alvotech (ALVO) Cash from Investing Activities (2022 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Cash from Investing Activities for 5 consecutive years, with -$44.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Investing Activities fell 56.53% year-over-year to -$44.8 million; the trailing twelve-month figure through Jun 2026 stood at -$146.2 million (down 224.04% YoY), and the FY2025 full-year result was -$104.2 million, down 452.34% from the prior year.
- Cash from Investing Activities grew to -$44.8 million in Q2 2026 per ALVO's latest filing, from -$46.2 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $22.8 million in Q3 2024 and bottomed at -$63.5 million in Q4 2022.
- Historically, Cash from Investing Activities has averaged -$24.9 million across 5 years, with a median of -$20.4 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities jumped 59.28% in 2024, then plunged 486.06% in 2025.
- Over 5 years, Cash from Investing Activities stood at -$63.5 million in 2022, then grew by 27.07% to -$46.3 million in 2023, then surged by 59.28% to -$18.9 million in 2024, then climbed by 16.44% to -$15.8 million in 2025, then slumped by 183.97% to -$44.8 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$44.8 million, -$46.2 million, and -$15.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 46.72 Bn | 43.07 Bn | 2.15 Bn | -491.00 Mn |
| 2 | Viatris | 19.64 Bn | 18.75 Bn | 1.46 Bn | -51.60 Mn |
| 3 | Dr Reddys Laboratories | 10.36 Bn | 10.22 Bn | 396.53 Mn | 40.52 Mn |
| 4 | Amneal Pharmaceuticals | 6.44 Bn | 6.39 Bn | 334.51 Mn | -122.74 Mn |
| 5 | Bausch Health Companies | 2.11 Bn | 1.24 Bn | 2.10 Bn | -93.00 Mn |
| 6 | Ani Pharmaceuticals | 1.88 Bn | 1.52 Bn | 165.89 Mn | -3.05 Mn |
| 7 | Alvotech | 1.83 Bn | 1.69 Bn | 2.56 Mn | -44.77 Mn |
| 8 | Amphastar Pharmaceuticals | 1.04 Bn | 751.07 Mn | 93.47 Mn | 44.87 Mn |
| 9 | Fennec Pharmaceuticals | 382.22 Mn | 340.97 Mn | 17.15 Mn | - |
| 10 | NutriBand | 94.45 Mn | 91.03 Mn | 181,874.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -44.77 Mn |
| Mar 31, 2026 | -46.20 Mn |
| Dec 31, 2025 | -15.77 Mn |
| Sep 30, 2025 | -39.45 Mn |
| Jun 30, 2025 | -28.60 Mn |
| Mar 31, 2025 | -20.40 Mn |
| Dec 31, 2024 | -18.87 Mn |
| Sep 30, 2024 | 22.75 Mn |
| Jun 30, 2024 | -7.09 Mn |
| Mar 31, 2024 | -3.48 Mn |
| Dec 31, 2023 | -46.34 Mn |
| Jun 30, 2023 | -11.35 Mn |
| Dec 31, 2022 | -63.54 Mn |
API Access
Alvotech Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ALVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "ALVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ALVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();